Synta Pharmaceuticals Announces Appointment of Sumant Ramachandra, M.D., Ph.D. as President, Research and Development
3/14/2013 6:47:25 AM
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the appointment of Dr. Sumant Ramachandra as President, Research and Development.
Prior to Synta, Dr. Ramachandra was Senior Vice President, Research and Development (R&D), Regulatory and Medical Affairs, and Chief Scientific Officer of Hospira, a specialty pharmaceuticals and medical device company.
comments powered by